vs
KinderCare Learning Companies, Inc.（KLC）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是KinderCare Learning Companies, Inc.的1.1倍（$772.1M vs $676.8M），Revvity净利率更高（12.7% vs 0.7%，领先12.1%），Revvity同比增速更快（5.9% vs 0.8%），Revvity自由现金流更多（$161.8M vs $62.6M）
金德凯尔学习公司是1969年成立的美国营利性早教与托育机构运营商，总部位于俄勒冈州波特兰市，服务覆盖全美39个州及华盛顿哥伦比亚特区，目前在全美拥有超1250家教学点，在读儿童约20万人，面向出生6周至12岁的儿童提供教育项目，是俄勒冈州第三大私营企业。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
KLC vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.1倍
$676.8M
营收增速更快
RVTY
高出5.1%
0.8%
净利率更高
RVTY
高出12.1%
0.7%
自由现金流更多
RVTY
多$99.2M
$62.6M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $676.8M | $772.1M |
| 净利润 | $4.5M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 3.9% | 14.5% |
| 净利率 | 0.7% | 12.7% |
| 营收同比 | 0.8% | 5.9% |
| 净利润同比 | -67.4% | 3.9% |
| 每股收益（稀释后） | $0.04 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KLCRVTY
| Q4 25 | — | $772.1M | ||
| Q3 25 | $676.8M | $698.9M | ||
| Q2 25 | $700.1M | $720.3M | ||
| Q1 25 | $668.2M | $664.8M | ||
| Q4 24 | $647.0M | $729.4M | ||
| Q3 24 | $671.5M | $684.0M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | — | $649.9M |
净利润KLCRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $4.5M | $46.7M | ||
| Q2 25 | $38.6M | $53.9M | ||
| Q1 25 | $21.2M | $42.2M | ||
| Q4 24 | $-133.6M | $94.6M | ||
| Q3 24 | $14.0M | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | — | $26.0M |
毛利率KLCRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率KLCRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | 3.9% | 11.7% | ||
| Q2 25 | 9.8% | 12.6% | ||
| Q1 25 | 7.3% | 10.9% | ||
| Q4 24 | -13.8% | 16.3% | ||
| Q3 24 | 8.1% | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | 6.8% |
净利率KLCRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | 0.7% | 6.7% | ||
| Q2 25 | 5.5% | 7.5% | ||
| Q1 25 | 3.2% | 6.4% | ||
| Q4 24 | -20.6% | 13.0% | ||
| Q3 24 | 2.1% | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）KLCRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $0.04 | $0.40 | ||
| Q2 25 | $0.33 | $0.46 | ||
| Q1 25 | $0.18 | $0.35 | ||
| Q4 24 | $-1.17 | $0.77 | ||
| Q3 24 | $0.15 | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $174.7M | $919.9M |
| 总债务越低越好 | $930.9M | — |
| 股东权益账面价值 | $931.2M | $7.3B |
| 总资产 | $3.9B | $12.2B |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
现金及短期投资KLCRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | $174.7M | $931.4M | ||
| Q2 25 | $119.0M | $991.8M | ||
| Q1 25 | $131.3M | $1.1B | ||
| Q4 24 | $62.3M | $1.2B | ||
| Q3 24 | $137.2M | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务KLCRVTY
| Q4 25 | — | — | ||
| Q3 25 | $930.9M | — | ||
| Q2 25 | $926.5M | — | ||
| Q1 25 | $927.4M | — | ||
| Q4 24 | $926.0M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KLCRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | $931.2M | $7.4B | ||
| Q2 25 | $924.3M | $7.6B | ||
| Q1 25 | $884.9M | $7.6B | ||
| Q4 24 | $864.5M | $7.7B | ||
| Q3 24 | $235.6M | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | — | $7.8B |
总资产KLCRVTY
| Q4 25 | — | $12.2B | ||
| Q3 25 | $3.9B | $12.1B | ||
| Q2 25 | $3.8B | $12.4B | ||
| Q1 25 | $3.7B | $12.4B | ||
| Q4 24 | $3.6B | $12.4B | ||
| Q3 24 | $3.7B | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | — | $13.4B |
负债/权益比KLCRVTY
| Q4 25 | — | — | ||
| Q3 25 | 1.00× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 6.42× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $62.6M | $161.8M |
| 自由现金流率自由现金流/营收 | 9.2% | 21.0% |
| 资本支出强度资本支出/营收 | 5.6% | 2.6% |
| 现金转化率经营现金流/净利润 | 22.15× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流KLCRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $100.8M | $138.5M | ||
| Q2 25 | $35.0M | $134.3M | ||
| Q1 25 | $98.4M | $128.2M | ||
| Q4 24 | — | $174.2M | ||
| Q3 24 | — | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | — | $147.6M |
自由现金流KLCRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $62.6M | $120.0M | ||
| Q2 25 | $671.0K | $115.5M | ||
| Q1 25 | $75.1M | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率KLCRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | 9.2% | 17.2% | ||
| Q2 25 | 0.1% | 16.0% | ||
| Q1 25 | 11.2% | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度KLCRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | 5.6% | 2.6% | ||
| Q2 25 | 4.9% | 2.6% | ||
| Q1 25 | 3.5% | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率KLCRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 22.15× | 2.97× | ||
| Q2 25 | 0.91× | 2.49× | ||
| Q1 25 | 4.65× | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KLC
| Early Childhood Education Centers | $627.0M | 93% |
| Before And After School Sites | $49.8M | 7% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
